Hem/Onc Roundup: Most cancers is the Main Explanation for Loss of life Amongst Sufferers with Diabetes within the UK, and Extra

0
306

This week the editors spoke to you in DocWire News DR. Raj Chakraborty, Assistant Professor of Medicine at Irving Medical Center, Columbia University, on promising research on bispecific T-cell engagers (BiTEs) for the treatment of multiple myeloma and considerations for choosing between BiTEs and T-cell therapy with chimeric antigen receptor (CAR).

Bispecific T-Cell Engagers for Multiple Myeloma with Dr. Chakraborty

– –

A systematic review of patients with breast cancer found that A quarter of the patients suffer from cognitive impairments before starting cancer therapy. Some patients showed improvement after treatment (15%) or after a year of follow-up (31%). Rates of cognitive decline appeared to vary by treatment, with a higher prevalence of long-term impairment in patients receiving chemotherapy.

Every fourth patient with breast cancer suffers from cognitive impairment

– –

Cancer, not vascular disease, is that Leading cause of death in people with diabetesAccording to a UK study. “Improvements in risk factors such as smoking and blood pressure, as well as advances in medical treatments, have contributed to sharp reductions in deaths from heart disease and stroke,” said lead study author Dr. Jonathan Pearson-Stuttard. “In contrast, improvements in cancer death rates have been much more modest, with improvements in diabetics lagging behind the general population.”

Cancer, no vascular disease, No. 1 cause of death in patients with diabetes

– –

In a survey of breast or prostate cancer patients who had recently received chemotherapy, the researchers found that most patients (84%) were using additional herbs and supplements or other medications that might be present interact with their cancer treatment. There were more than 600 unique drug interactions before, during, and after chemotherapy, most of which occurred during chemotherapy. “Patients should be educated about the risk of herb and supplement drug interactions during treatment,” recommended the study’s authors.

How do herbs and supplements interact with chemotherapy?